Raymond James Financial Inc Immunome Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Immunome Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 25,817 shares of IMNM stock, worth $292,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,817Holding current value
$292,764% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
126Shares Held
46.4MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$65.3 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$55.4 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$44 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$42.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$39.6 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $138M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...